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INTRODUCTION
Sex differentiation is an elaborated cascade which
requires participation of many different genes (1-3).
In male differentiation, indifferent gonad (bipotent
gonad) is differentiated into fetal testis after the ex-
pression of SRY (sex-determining region onY). During
¨sex differentiation for males, Mullerian inhibitory
substance (MIS) is expressed by Sertoli cells of fetal
¨testis and induces regression of the Mullerian duct
that forms the anlagen of the uterus, oviducts, andupper
part of the vagina (4). For sex differentiation for females,
MIS is not produced by the ovaries during fetal de-
velopment (5). However, it is produced by granulosa
cells of developing follicles in postnatal ovaries (5).
Recent studies have revealed that theMIS expression
is regulated by several transcription factors (6-9). In
fetal Sertoli cells, SF-1up-regulates the expression of
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MIS through its binding to the two binding sites within
the proximal MIS promoter (6). Situated there are the
binding sites of SOX9 andGATA4, which are presumed
to have important roles for male sex-differentiation,
within the proximalMIS promoter (6). SOX9andGATA4
activate theMIS gene expression through their binding
to the MIS promoter and synergistic interaction with
SF-1 (6-9).WT-1also activatesMIS gene by interaction
with SF-1, while DAX-1inhibits the MIS expression
by interaction with SF-1 (9, 10).
In the last few years, growing attention has focused
on estrogen-like activity exerted by the endocrine
disruptors (EDs), which includes pharmacological
compounds, pesticides and industrial by-products
whose environmental levels have been suggested to
increase health risks (11). Some of these compounds
can bind to ERs as either agonist or antagonists of
the steroid hormone (12). Estrogens are known to be
important for the development and the function of the
reproductive system (13, 14). It is possible that estrogen-
mimics perturb the function of the reproductive system.
For example, the clinical use of diethylstilbestrol (DES)
by pregnant women has resulted in the presence of
¨the Mullerian duct remnants of in live fetus (15). The
prenatal exposure to diethylstilbestrol delayed the
¨onset of Mullerian duct formation in fetal male mice
(16). The expression of MIS was up-regulated in the
female mice without both estrogen receptorα and β,
suggesting that estrogen inhibits the expression of
MIS (17). However, it was also reported that the ex-
pression of MIS was up -regulated by estrogen (16).
Therefore, we set out to determine what has on
estrogen affects the MIS promoter activity.
Here, we show that ER α and ER β have different
effects on the MIS promoter activity in the NT2/D1
cells, which was derived from a human testicular em-
bryonal cell carcinoma. Furthermore, we also show
that the ERα-E 2 complex repressed theMIS promoter
activity mediated with SF-1 in those cells.
MATERIALS AND METHODS
Preparation of the human MIS promoter-firefly luciferase
reporter construct
HumanMIS promoter a 273 bp fragment was ampli-
fied using a PCR technique using normalmale genomic
DNA as a template (upstream primer : 5’-CTCGAGGG
ACAGAAAGGGCTCTTTGA-3’. downstream primer :
5’-AGATCTCGTGGGTGCTGCCAGGGGCT-3’), and
was cloned into pGL3-basic usingBglⅡandXhoⅠsites.
ERα-pSG5 and SF-1-pBluescript, which were used
for over-expression ofERαandSF-1,were fromDr.Jean-
Marc. Vanacker (Lyon, Cedex, France). To insert into
the pCXN2 vector, SF-1 cDNA was modified with a
PCR technique using SF-1-pBluescript as a template.
pCXN2 empty vector was obtained fromDr. Miyazaki
(Osaka, Japan)(18). Authenticity of all constructs was
confirmed by sequencing. Thoseconstructswere shown
to work well in the NT2/D1cells with RT-PCR analysis.
Transfection of plasmid DNA and dual luciferase assay
The NT2/D1cells and the human fetal fibroblast
cells (ATCC) were cultured in Dulbecco’s modified
Eagle’s medium (DMEM), which contained no phenol
red and was supplemented with 10% fetal calf serum,
penicillin-streptomycin at 37℃ina5%CO2. then, 100 ng
MIS -273-pGL 3 basic reporter plasmid, 10ngpRL-TK
Renilla luciferase plasmid and 50 ng of ERα-pSG5 or/
and 50ngofSF-1-pCXN2wereco-transfected into thecells
using FuGENE6 transfection reagent (Roche) according
to the manufacturer’s method. Dual luciferase assay
was performed by at least three separate transfections
in triplicate using picha gene dual luciferase Assay Kit
(Toyo Ink) according to themanufacturer’s instructions.
RT-PCR
Total RNA from the NT2/D1 cells were isolated
by TRIzol Reagent (invitrogen) according to the
manufacturer’s method. Then 2.5µg of the total RNA
was subjected to reverse transcription. The condition
for PCR was as follows : initial denaturation at 94℃
for 30 secs, annealing at 55℃(ERα, ERβ) or 63℃(MTS)
for 30 secs and extension at 72℃ for 1min. The PCR
was carried out in 35 cycles. The final extension step
was at 72℃ for 10min. The reactionmixture consisted
of 2.0 µl of cDNA, 10×PCR buffer, 0.8 mM dNTPs,
primers and 0.5 units of Taq polymerase in a total
volume of 20 µl. ThePCRproductswere loadedon2.5%
agarose gel with 1×TBE as buffer andwere visualized
with ethidium bromide staining. The primers used for
MIS were as follows : the forward primer : 5’-GCAA
CACCGGTGACAGGCAG -3’, and the reverse primer :
5’-CAGCCCTCGTCACAGTGACC-3’. The primers
used for ERα were as follows : the forward primer :
5’-ACTGTGCAGTGTGCAATGAC-3’, and the reverse
primer: 5’-CATCATCTCTCTGGCGCTTG-3’.Theprimers
used for ERβ were as follows : the forward primer :
5’-ATCGCTAGAACACACCTTAC-3’, and the reverse
primer:5’-CACTTCGTAACACTTCCGAA-3’. All primer
sets for amplification of cDNA were generated to
encompass at least one intron in each gene.
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RESULTS
NT2/D1 cell line expresses ERα and ERβ
Some studies reported that the NT2/D1cell line
expresses the genes participating in sex-determination
or sex-differentiation such as SRY, SOX9 and DAX-1
(6,19). To elucidate whether MIS is expressed in this
cell line, we carried out RT-PCR analysis using a MIS-
specific primer set. As a result, we found thatMISwas
expressed at a low level in theNT2/D1 cell line (Fig.1a).
Therefore, we used this cell line formolecular analysis
for effects of estrogen on theMIS expression. When
we tested whether ERα and ERβ are expressed in the
NT 2/D 1 cell line using RT-PCR, we found that both
genes were expressed in this cell line (Fig.1b, 1c).
To clarify whether estrogen has some effects on the
expression ofMIS,wecarriedoutdual luciferase reporter
assay to assess theMIS promoter activityunder different
concentrations of β-estradiol (E2). It was reported that
a 273 bp DNA fragment upstream from the translation
initiation codon of the MIS was important for MIS
expression (6). This fragment contains a SOX9 binding
site and two SF-1binding sites, and those transcription
factors were suggested important forMIS expression
(6). Therefore, we generated a firefly luciferase reporter
construct that possesses the 273 bp DNA fragment
of the MIS promoter, designed as pGL3 -MIS 273,
according to a previous study (6). The sequence of
the human proximal MIS promoter is shown in Fig.2.
When we cultured the NT2/D1 cells using theme-
dium containing the fetal calf serum stripped for lipid-
soluble hormones, those cells could not growth. There-
fore, in thepresent study,weculturedcells in themedium
that was not stripped for lipid-soluble hormones. The
concentration of E2 in the fetal calf serumwas approx-
imately 22.84 pg/ml(0.08nM), according to the certificate
Fig. 1. Analysis of MIS and ERs expression in the NT2/D1
cells. (a) RT-PCR detection ofMIS in the NT2/D1 cell line. lane1,
DNA marker φ 174/HaeⅢ; lane2, cDNA derived from the NT2/D1
cells ; lane 3, genomic DNA ; lane 4, cDNA derived from human
fetal fibroblast ; lane 5, water. The arrow corresponds to a MIS-
specific band which was confirmed with direct sequencing. Some
non-specific bands were observed sinceMIS cDNA is highly rich in
guanine and cytosine. The clear band observed in lane 3 showa non-
specific band derived from genomic DNA. (b) RT-PCRdetection of
ERα. lane 1, DNA marker φ 174/Hae Ⅲ ; lane 2, cDNA ; lane 3,
genomic DNA ; lane 4, water. The arrow shows a ERα-specific band.
The band observed in lane 3 corresponds to a genomic fragment.
(c) RT-PCR detection of ERβ. lane1, DNA marker φ174/HaeⅢ;
lane 2, water ; lane 3, cDNA ; lane 4, genomic DNA. The arrow
shows a ERβ-specific band.
Fig. 2. The sequence of the human MIS proximal promoter. Bold letters correspond to the binding sequences of the
transcription factors. Ⅰ, ERE-like motives ; Ⅱ, SF-1 binding sites ; Ⅲ, SOX binding site ; Ⅳ, TATA box
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of product.
When the amount of E2 in the culturemediumwas
increased, no apparent dose-dependent effects of E2
on theMIS promoter was observed (Fig. 3). However,
we could not rule out the possibility that the amount
of ERs expressed in theNT2/D1 cells was inadequate
to exhibit their functions. Semi-quantitative RT-PCR
analysis of the twoERsunder thedifferent concentrations
of E2 could not reveal significant alterationsof expression
of both ERs (data not shown).
Over-expression of ERα increases the MIS promoter
activity
To over-express ERα or ERβ in the NT2/D1cells,
ERα-pSG5 and ERβ-pCXN2 were transfected into the
NT2/D1 cells.WhenERα or ERβwere over-expressed
in the NT2/D1 cells under several concentrations
of E2, the twoERswere completely different in the dose-
responsiveness to E2 for the MIS promoter activity
(Figs. 4, 5).
For ERα, the MIS promoter activity was increased
3.3-fold comparedwith the controls under no additional
E2 to the medium (Fig.4). As the E2 concentration
was increased, theMIS promoter activity was decreased
(Fig. 4). When E2 was added in the medium up to final
concentrations of 10 nM, the activity ofMIS proximal
promoter became almost one-third compared with
no additional E2 (Fig.4). To confirm that ERα has
transcriptional activity in theNT2/D1cells, the reporter
construct, which contains a firefly luciferasegene ligated
with a thymidine kinase minimum promoter and es-
trogen responsive element (ERE), was co-transfected
into the NT2/D1cells with the ERα over-expression
vector. As a result, the reporter gene activity was in-
creased according to the concentrationsofE2, suggesting
that the exogenous ERα can work in theNT2/D1 cells
(data not shown).
In contrast to ERα, for ERβ, the response of the
MIS promoter to E2, which was observed for ERα,
was not detected, and the promoter activity was similar
to the controls, suggesting that the type of ERs is crucial
for regulation of the MIS promoter activity (Fig.5).
ERα affects SF-1-dependent MIS proximal promoter
activity
When SF-1 and ERα were simultaneously over-
expressed in the NT2/D1 cells, it became clear that
the MIS promoter activity was similar to that observed
for SF-1alone which increased the promoter activity
Fig. 3. The MIS promoter activity in the NT2/D1cells under
the different concentrations of E2. The lanes andE2 concentrations
in each sample are below.
“+” indicates addition of pGL3-MIS 273. Fold activation was
compared with pGL3-MIS 273 alone, lane 1. Errors bars show
the standard error.
Fig. 4. The effects of over- expression of the ERα on the MIS
promoter activity.
The lanes and expression constructs in each sample are below.
“+” and “-”indicate addition and omission, respectively. pSG 5
is an empty expression vector. Fold activation was compared
with lane 1.Errors bars show the standard error.
Fig. 5. The effects of over- expression of the ERβ on the MIS
promoter activity. The lanes andexpression constructs in each sample
are below. “+” and “-” indicate addition and omission, respectively.
pCXN 2 is a empty expression vector. Fold activation was
compared with lane 1. Errors bars show the standard error.
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by 2.5-fold compared with the control (Fig.6). This
result suggested that SF-1inhibits the MIS promoter
activity mediated with ERα (Fig.6). Furthermore, the
MIS promoter activitymediatedwithSF-1was repressed
in a E2 dose-dependent manner (Fig.6).
DISCUSSION
One of major targets for EDs is thought to be a sex
differentiation systemduring fetal stage (11).MIShas
¨important roles for regression of the Mullerian duct
during male sex differentiation (1-4). Therefore, we
addressed whether E2 affects the MIS expression
in the promoter level using theNT2/D1 cells as amodel
of the pre-mature Sertoli cell.
ERs areknown tobedifferent in their tissuedistributions
and presumed functions (20). In the present study,
over-expression of twoERs in theNT2/D1 cells demon-
strated that ERα but not ERβ up-regulated the MIS
promoter activity. Furthermore, we showed that theMIS
promoter activity mediated with ERαwas repressed
in an E2 dose-dependent manner.
It was reported that DES-exposed fetus exhibits a
¨delay in the formation and regression of the Mullerian
duct (15, 16). Therefore, it may be possible that one
of the effects of E2 on the sex differentiation may be
to change the timing of the initiation for formation and
¨regression of the Mullerian duct (16).
It was reported that SF-1is expressed in the fetal
Sertoli cells and has important roles for expression of
MIS (6-9, 21). The present results suggested that the
MIS expression mediated with SF-1may be influenced
by E2 through ERα. However, in the fragment of the
MIS promoter used in the present study,which contained
a 273 bp region upstream from the translation start
codon of the MIS gene, there is no complete estrogen
receptor response element (6). However, there are two
SF-1 binding sites that containEREhalf-site likemotives
and four sequences similar to ERE half-sites (Fig.2).
For examples, Jena-Marc Vanacker et al reported that
ERα but not ERβ binds to SF-1 response elements and
activates the osteopontin gene promoter (22). Indeed,
since thereare twoSF-1 responseelements,whichcontain
similar sequences with halfmotives of ERE, in theMIS-
273 bp promoter, ERαmay bind to them.
There are some studies that reported that ligand-
free and ligand-bound nuclear receptors have different
functions for the transcription of their target genes (23,
24). The findings of present study suggested that ERα
up-regulated transcriptional activity of the humanMIS
promoter under low concentrations of E2, and that it
was decreased as the concentration of E2was increased.
Although we could not remove estrogens completely
because the NT2/D1 could not survive without lipid-
soluble hormones, it is possible that ligand-unbound
ERα up-regulated transcriptional activity of the human
MIS promoter.
For ERβ, Shapiro et al. has reported thatE2-unbound
ERβ induced the high constitutive activity of 5.5 kb
rat vasopressin promoter and that the E2-bound ERβ
inhibited the high constitutive activity (25). They re-
ported that the constitutive activity of ERβmay be due
to transcription from anAP1-like sequence, whichwas
not found in theMIS promoter region analyzed in the
present study (25). In present study, over-expression
of ERβ did not show the response of theMIS promoter
to E2, which was observed for ERα.
Some hypotheses appear to explain that SF-1 an-
tagonizes the effect of ERα on theMIS promoter. First,
the SF1-response elements may be important for both
ERα to bind to the human MIS promoter, and SF-1
may compete with ERα for its bindingsites (22). Second,
since ERα can physically interact with SF-1 (26), this
interaction may lead to block access of ERα to theMIS
promoter.
In the present study, when SF-1andERαwere simul-
taneously over-expressed in the NT2/D1 cells, the
MIS promoter activity was decreased as the E2 concen-
tration was increased. LigandedERαmay be different
from the un-liganded one in the interactionwith SF-1or
the affinity to theMIS promoter. We may also have to
pay attention to the possibility that ERα exhibits non-
genomic functions in a ERE-independent manner
Fig. 6. SF-1inhibits ERα-mediated activation of theMIS promoter
and E2 affects theMISpromoter activitymediatedwith SF-1 through
ERα. The lanes and expression constructs in each sample are below.
“+” and “-” indicate addition and omission, respectively. There is
a significant difference (p<0.05) between the results in lane 2 and
lane 6 by unpairedStudent’s t test. There is also a significant difference
(p<0.01) between the results lane 2 and lane 7.
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to affect the functions of SF-1 (27, 28). To test these
hypotheses, future studies are required.
In conclusion, although it remains unclear whether
the effects of ERα on theMIS promoter are mediated
through the genomic or non-genomic actions, the
present results may suggest that ERα up-regulates
the MIS promoter activity under low concentrations
of E2 and that it inhibits the effects of SF-1 on theMIS
promoter. The present findingsmay be useful to under-
stand themolecularmechanismsbywhichEDsorDES
affects the MIS expression.
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